SCHEMBL2216644

SCHEMBL2216644

O=C1CNCC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3910040 0.84 TRIM24 (0.31)
Hydrochloric Acid SCHEMBL1771294 0.84
Hydrochloric Acid SCHEMBL27001775 0.80
SCHEMBL6434771 0.74 TRIM24 (0.36)
SCHEMBL3619632 0.71 CYP1A2 (0.61)
SCHEMBL17435216 0.70
SCHEMBL1160928 0.69
SCHEMBL1431864 0.69
SCHEMBL232122 0.69
SCHEMBL27583411 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-56005461-A None JP disclosed
JP-56002984-A None JP disclosed
JP-56007765-A None JP disclosed
EP-3998260-B1 SGC STIMULATORS CYCLERION THERAPEUTICS INC (US) 2023-11-01 EP disclosed
CN-116969904-A Compounds useful as autophagy modulators, methods of preparation and uses thereof 微境生物医药科技(上海)有限公司 2023-10-31 CN disclosed
CN-111148740-B Compounds useful as autophagy modulators, methods of preparation and uses thereof 微境生物医药科技(上海)有限公司 2023-08-25 CN disclosed
CN-109369635-B Compound or pharmaceutically acceptable salt thereof, application thereof and pharmaceutical composition 赛克里翁治疗有限公司 2023-06-30 CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 US disclosed
US-20230106002-A1 sGC STIMULATORS IRONWOOD PHARMACEUTICALS, INC. 2023-04-06 US disclosed
CN-109384778-B Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder 赛克里翁治疗有限公司 2022-12-13 CN disclosed
EP-1571148-A1 3-PHENYL-CINNOLINE HOMOLOGUE AND ANTITUMOR AGENT CONTAINING THE SAME Nippon Kayaku Kabushiki Kaisha (JP) 2005-09-07 EP disclosed
EP-1259510-A2 TRICYCLIC DIHYDROPYRAZOLONE AND TRICYCLIC DIHYDROISOXAZOLONE POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2002-11-27 EP disclosed
WO-2001066544-A2 TRICYCLIC DIHYDROPYRAZOLONE AND TRICYCLIC DIHYDROISOXAZOLONE POTASSIUM CHANNEL OPENERS ABBOTT LABORATORIES (US) 2001-09-13 WO disclosed
EP-0059291-B1 ANTIHYPERTENSIVE AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1985-03-27 EP disclosed
US-4365063-A Antihypertensive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1982-12-21 US disclosed
EP-0059291-A1 Antihypertensive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1982-09-08 EP disclosed
US-4321384-A Antihypertensive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1982-03-23 US disclosed
JP-S567765-A 4,4'-METHYLENEBIS-(1-SUBSTITUTED-3-PHENYLAMINO-5-OXO-3,4-DEHYDROPIPERIDINE) DERIVATIVE TAMURA YASUMITSU 1981-01-27 JP disclosed
JP-S565461-A 1-SUBSTITUTED-3-ANILINO-4-DIALKYLAMINOMETHYL-5-OXO-3,4- DEHYDROPIPERIDINE TAMURA YASUMITSU 1981-01-20 JP disclosed
JP-S562984-A 1,2,3,5,6,11-HEXAHYDRO-5-PHENYL-4H-PYRIDO(3,4-B)(1,5)BENZODIAZEPIN-4-ONE DERIVATIVE TAMURA YASUMITSU 1981-01-13 JP disclosed